• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Serica Technologies

Report: Despite settlement, patient seeks prosecution for off-label Seri scaffold breast surgery

December 21, 2018 By Fink Densford

A patient in Southern California who underwent breast reconstruction surgery using an off-label Seri surgical scaffold is pushing for the state to prosecute the operating plastic surgeon, despite having received $1 million in a settlement, over claims that he altered her medical records, according to a Pasadena Star News report. The patient, Wendy Knecht, underwent […]

Filed Under: Cosmetic/Aesthetic, Legal News, Women's Health Tagged With: Allergan, Serica Technologies, Sofregen Medical

Sofregen buys Allergan’s Seri surgical scaffold

November 14, 2016 By Sarah Faulkner

Sofregen Medical said today that it bought the Seri surgical scaffold from Allergan (NYSE:AGN) for an undisclosed amount. Polaris Partners and other investors provided financing for the acquisition, according to the Medford, Mass.-based company. Seri, which is approved by the FDA for use as soft tissue support in plastic and reconstructive surgical procedures, is the only approved […]

Filed Under: Materials Testing, Regenerative Medicine, Surgical Tagged With: Allergan, Serica Technologies, Sofregen Medical

Sofregen lands $6.2m Series A

September 16, 2016 By Sarah Faulkner

Sofregen Medical said yesterday that it landed a $6.2 million Series A round from Polaris Partners and other founding investors, bringing their total funding raised to more than $11 million. The Medford, Mass.-based company was founded in 2014 to advance silk-based medical technology developed at Tufts University and the University of Pittsburgh for soft tissue […]

Filed Under: Funding Roundup, Materials Testing, Regenerative Medicine, Surgical Tagged With: Serica Technologies, Sofregen Medical

FDA Warns Allergan over Seri scaffold

June 10, 2015 By Fink Densford

The FDA warned Allergan last month about marketing the Seri surgical scaffold in the U.S. for breast surgery indications without marketing clearance or approval. An FDA review of Allergan’s Seri website reported the scaffold was being marketted for breast surgery applications, which the federal watchdog says “would constitute a major change or modification to its […]

Filed Under: Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Allergan, FDA, Serica Technologies

Allergan buys Serica Technologies for undisclosed amount

February 4, 2010 By MassDevice staff Leave a Comment

Allergan Inc. (NYSE:AGN) acquired Serica Technologies Inc. for an undisclosed amount.

Medford, Mass.-based Serica, which is developing silk-based biomaterials for tissue repair, will become a wholly owned subsidiary of Irvine, Calif.-based Allergan, which makes products ranging from Botox to Lap-Band gastric banding systems.

Filed Under: Biotech, Business/Financial News, News Well Tagged With: Allergan, Serica Technologies, Tissue Regeneration

MassDevice Q&A: Serica Technologies CEO Greg Altman

December 28, 2009 By Brad Perriello

Thirteen years ago Greg Altman, president and CEO of Serica Technologies Inc., blew out his knee playing football. After reconstructive surgery on his ruptured anterior cruciate ligament, the former All-American at Tufts University found the rehabilitation process so challenging that he set out to develop an alternative.

Filed Under: Biotech, Business/Financial News Tagged With: MassDevice Q&A, Serica Technologies

FDA hops onto Serica’s SeriScaffold

February 25, 2009 By MassDevice staff

The U.S. Food and Drug Administration hopped onto Serica Technologies Inc.’s SeriScaffold product, granting the silk-based surgical mesh clearance to hit the market.

The Medford-based growth-stage device maker’s flagship product is designed to repair and remodel damaged connective tissue, avoiding the erosion and scar formation that can result from surgery.

Filed Under: Business/Financial News, Surgical Tagged With: Serica Technologies

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS